LoginSignup
Imagen de perfil
Bimbam
@Klambam
1Año·

Has anyone read news about $IBRX (-0,16 %) or knows what is going on? Almost 300% in one month.

1
11 Comentarios
Imagen de perfil
Patrick ₿ateman@fastlane
1Año
„NATIONAL MULTICENTER TRIAL OPENS TO STUDY IMMUNITYBIO'S TRI-AD5 CANCER
VACCINES PLUS N-803 TO PREVENT CANCER IN PEOPLE WITH LYNCH SYNDROME“ - Reuters
•
2
•
Imagen de perfil
Yassin@RisingAktie
1Año
Wanted to expand my position the other day when they were at just under € 2, but then they were already slowly shooting up again. Stupid timing until the money was on deposit :(
•
2
•
Ver todas las 3 respuestas adicionales
Imagen de perfil
Nico@itZNico
1Año
"The increase in share prices is likely due to the positive momentum building around the company's lead pipeline candidate, N-803. The FDA is currently reviewing a regulatory submission for N-803 in combination with Bacillus Calmette-Guerin (BGC) for the treatment of patients with bladder cancer." Source: https://www.zacks.com/stock/news/2091284/immunitybio-ibrx-stock-jumps-432-will-it-continue-to-soar
•
1
•
Imagen de perfil
Bimbam@Klambam
1Año
@Clermit that did not run with as hoped. rebuy? 😂
•
1
•
Mostrar respuesta
Imagen de perfil
MarsEquities@CircusClown
1Año
What the others have already mentioned + general strength in biotech in recent weeks + insider buying in April by Soon-Shiong. IBRX was also sold off massively before that. YTD it is still "only" 22% up.
••
Ver todas las 2 respuestas adicionales
Únase a la conversación
InscríbaseInicio de sesión